| PERIOD ENDING | 1-Mar-09 | 2-Mar-08 | 25-Feb-07 | | Total Revenue | 200,062 | 241,852 | 257,377 | | Cost of Revenue | 156,638 | 179,398 | 193,270 | | | Gross Profit | 43,424 | 62,454 | 64,107 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 24,806 | 27,159 | 26,682 | | Non Recurring | 6,257 | 1,362 | 1,316 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 12,361 | 33,933 | 36,109 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,648 | 9,361 | 8,033 | | Earnings Before Interest And Taxes | 19,009 | 43,294 | 44,142 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 19,009 | 43,294 | 44,142 | | Income Tax Expense | 495 | 8,615 | 4,351 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 18,514 | 34,679 | 39,791 | | | Non-recurring Events | | Discontinued Operations | 16,486 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 35,000 | 34,679 | 39,791 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $35,000 | $34,679 | $39,791 |
|
1.48% Nasdaq 
Income Statement
